Gain Therapeutics, Inc. (GANX)
NASDAQ·Healthcare·Biotechnology
$1.75
+2.34%
Mkt Cap $76.78M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (5 analysts)
$7.80
Range $4.00 – $10.00
Implied Upside
+345.7%
Consensus $7.80 vs current $1.75
NASDAQ·Healthcare·Biotechnology
$1.75
+2.34%
Mkt Cap $76.78M
Buy
3
Hold
0
Sell
0
Price Target (5 analysts)
$7.80
Range $4.00 – $10.00
+345.7%
Consensus $7.80 vs current $1.75